A novel model of CCl4-induced cirrhosis with ascites in the mouse.
about
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under DevelopmentSuccessful chemoimmunotherapy against hepatocellular cancer in a novel murine model.MRI tracking of macrophages labeled with glucan particles entrapping a water insoluble paramagnetic Gd-based agent.Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride-induced liver cirrhosis.Metabolic Profile of Obeticholic Acid and Endogenous Bile Acids in Rats with Decompensated Liver CirrhosisInhibition of acidic sphingomyelinase reduces established hepatic fibrosis in miceMouse models of liver fibrosis mimic human liver fibrosis of different etiologies.MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis.Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.Baicalein reduces the occurrence of cirrhotic endotoxemia by reducing intestinal mucosal apoptosisProtective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury.Experimental models of liver fibrosisExperimental liver fibrosis research: update on animal models, legal issues and translational aspects.Role of hemostatic factors in hepatic injury and disease: animal models de-liver.Silymarin Protects Mouse Liver and Kidney from Thioacetamide Induced Toxicity by Scavenging Reactive Oxygen Species and Activating PI3K-Akt Pathway.Hepatoprotective effects of mushrooms.Animal models of hepatotoxicity.Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.The carbon tetrachloride model in mice.Bile duct-ligated mice exhibit multiple phenotypic similarities to acute decompensation patients despite histological differencesHepatoprotective activity of cinnamon ethanolic extract against CCI4-induced liver injury in rats.Establishment of a reversible model of prehepatic portal hypertension in rats.Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.Levistilide A inhibits angiogenesis in liver fibrosis via vascular endothelial growth factor signaling pathway.A new BODIPY-based long-wavelength fluorescent probe for chromatographic analysis of low-molecular-weight thiols.Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer.A novel canine model of portal vein stenosis plus thioacetamide administration-induced cirrhotic portal hypertension with hypersplenism.Hepatoprotective potential of new steroid against carbon tetrachloride-induced hepatic injury.Hepatoprotective effects of Portulaca oleracea extract against CCl4-induced damage in rats.Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways.
P2860
Q26781761-3D5F481E-1311-43B2-945C-15466AADF692Q30276134-85409C05-D338-400C-B08E-6AE3EDC993E5Q30578470-96FB6FEE-461D-4644-B79F-C4A30A64BF31Q33567439-A0D862F9-8107-4347-A4F1-E77F2E8F12BBQ33891552-8D1EB5C9-C6BA-40AB-9C35-7AD6DA8194ACQ34451277-3C30E576-2BC0-4A6F-B3E8-E2D1760C5946Q34482519-696C8021-EF87-4484-B675-0E725F1CBF79Q34675280-34C5A1FD-6CC5-440A-AD18-A82840DF61A0Q35167959-3DF15A24-108F-44A6-A36C-1D47CD3E4D55Q35209239-2C904684-53AE-4AE6-B5E4-AFE104F54442Q35645328-0DA90CBA-4985-4AA2-BC85-F8A881869C66Q35922580-B4B40BEA-A52C-4FD2-AD49-82B94E4AECE9Q36442525-54452BEC-4E40-40DE-801E-5CFD14940FB4Q37363773-3C1366CC-D12B-4BA5-B2B6-782F714378B8Q37387653-4D3C4847-3EBE-4C1A-9113-56E8FEFCBAFAQ37504567-DE257719-CBB2-4BD3-9251-C059825C285EQ38123952-49ED0362-DC67-4477-AC5D-8950F60CDD2BQ38596917-F6790012-D517-4684-A2CA-11FF3C4AA629Q41029212-83955C79-43C3-494D-83C0-4421DE9CE327Q41121854-C99CA4E2-68DA-403A-B054-D00B73C56427Q41201824-6F23F467-B56B-4686-BB5B-3B56EA2C3976Q41570242-AFD4F6AB-D6B9-4D23-B0BB-9D050D31DB27Q42038468-B4F4874E-144E-48A6-A417-094147461B94Q42293558-104DE7F1-3842-4077-B14D-125F7C93935CQ43104909-3C822901-8238-482D-A746-11E62A88C984Q47439720-3EAFEC4F-016B-425F-93B4-34B0824843CAQ50546690-24008671-BA1F-4617-8B6A-443DC98DB51BQ53220626-62BE4C7E-0349-4B69-B9C6-13ED133DA780Q53256520-2AA4521E-BEAB-4DFA-A919-7600A547B10DQ53677351-29EA0D5A-5DF2-42F3-B8C4-14FA3CEF84EFQ53817185-165B99B1-9F4A-4FC1-BCAD-8FBF527A5601Q55408871-24C0C769-AB7B-4C7B-AA8C-3883CE88E823
P2860
A novel model of CCl4-induced cirrhosis with ascites in the mouse.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A novel model of CCl4-induced cirrhosis with ascites in the mouse.
@en
A novel model of CCl4-induced cirrhosis with ascites in the mouse.
@nl
type
label
A novel model of CCl4-induced cirrhosis with ascites in the mouse.
@en
A novel model of CCl4-induced cirrhosis with ascites in the mouse.
@nl
prefLabel
A novel model of CCl4-induced cirrhosis with ascites in the mouse.
@en
A novel model of CCl4-induced cirrhosis with ascites in the mouse.
@nl
P2093
P1476
A novel model of CCl4-induced cirrhosis with ascites in the mouse.
@en
P2093
Carmelo Quarta
Corrado Patti
Cristina Nanni
Ferdinando Giannone
Giovanna Lucchetti
Marco Domenicali
Maurizio Baldassarre
Mauro Bernardi
Paolo Caraceni
Roberto M Lemoli
P304
P356
10.1016/J.JHEP.2009.09.008
P50
P577
2009-10-07T00:00:00Z